Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Oliver C. Watkins, Hannah E. J. Yong, Neha Sharma & Shiao-Yng Chan. (2022) A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. Critical Reviews in Food Science and Nutrition 62:6, pages 1626-1673.
Read now
Read now
Antonio Simone Laganà, Gianpiero Forte, Mariano Bizzarri, Zdravko A. Kamenov, Bianca Bianco, Cihan Kaya, Georgios Gitas, Ibrahim Alkatout, Milan Terzic & Vittorio Unfer. (2022) Inositols in the ovaries: activities and potential therapeutic applications. Expert Opinion on Drug Metabolism & Toxicology 18:2, pages 123-133.
Read now
Read now
Jiaqi Zhang, Chuan Xing, Han Zhao & Bing He. (2021) The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis. Gynecological Endocrinology 37:12, pages 1063-1071.
Read now
Read now
Giuseppe Derosa, Angela D’Angelo, Arianna Vanelli & Pamela Maffioli. (2020) An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia. Diabetes, Metabolic Syndrome and Obesity 13, pages 653-661.
Read now
Read now
Paolo Giovanni Artini, Maria Elena Rosa Obino, Elisabetta Micelli, Elisa Malacarne, Chiara Vacca, Francesca Papini & Vito Cela. (2020) Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women. Gynecological Endocrinology 36:9, pages 755-759.
Read now
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Read now
Elene Asanidze, Jenaro Kristesashvili, Lali Pkhaladze & Archil Khomasuridze. (2019) The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents. Gynecological Endocrinology 35:11, pages 974-977.
Read now
Read now
Anisha Agrawal, Reeta Mahey, Garima Kachhawa, Rajesh Khadgawat, Perumal Vanamail & Alka Kriplani. (2019) Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecological Endocrinology 35:6, pages 511-514.
Read now
Read now
Maryam Shokrpour, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Zahra Vahedpoor, Esmat Aghadavod, Amir Ghaderi & Zatollah Asemi. (2019) Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecological Endocrinology 35:5, pages 406-411.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
Paolo Giovanni Artini, Maria Elena Rosa Obino, Claudia Sergiampietri, Sara Pinelli, Francesca Papini, Elena Casarosa & Vito Cela. (2018) PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome. Expert Review of Endocrinology & Metabolism 13:2, pages 87-98.
Read now
Read now
Özlen Emekçi Özay, Ali Cenk Özay, Erkan Çağlıyan, Recep Emre Okyay & Bülent Gülekli. (2017) Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. Gynecological Endocrinology 33:7, pages 524-528.
Read now
Read now
Vittorio Unfer, Beatrice Orrù & Giovanni Monastra. (2016) Inositols: from physiology to rational therapy in gynecological clinical practice. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1129-1131.
Read now
Read now
Ewa M. Milewska, Adam Czyzyk, Blazej Meczekalski & Alessandro D. Genazzani. (2016) Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology 32:9, pages 690-695.
Read now
Read now
Cristiana Paul, Antonio Simone Laganà, Paolo Maniglio, Onofrio Triolo & David M. Brady. (2016) Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 32:6, pages 431-438.
Read now
Read now
Zdravko Kamenov, Georgi Kolarov, Antoaneta Gateva, Gianfranco Carlomagno & Alessandro D. Genazzani. (2015) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology 31:2, pages 131-135.
Read now
Read now
Articles from other publishers (67)
Sayeree Joardar, Prangan Duarah & Mihir Kumar Purkait. (2023) Recent advances in myo-inositol recovery and purification from agricultural sources as potential dietary supplements: A review. Sustainable Chemistry and Pharmacy 36, pages 101331.
Crossref
Crossref
Zdravko Kamenov, Antoaneta Gateva, Simona Dinicola & Vittorio Unfer. (2023) Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome. Metabolites 13:6, pages 717.
Crossref
Crossref
A. I. Turchinets, E. V. Uvarova, E. P. Khashchenko & Z. Kh. Kumykova. (2023) Target therapy of polycystic ovary syndrome. Meditsinskiy sovet = Medical Council:5, pages 7-13.
Crossref
Crossref
Samradhi Singh, Namrata Pal, Swasti Shubham, Devojit Kumar Sarma, Vinod Verma, Francesco Marotta & Manoj Kumar. (2023) Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of Clinical Medicine 12:4, pages 1454.
Crossref
Crossref
Maryam Haghighi, Mehdi Mehdizadeh, Fatemehsadat Amjadi, Zahra Zandieh, Mohammad Najafi, Tayebe Artimani, Fatemeh Mohammadi & Rana Mehdizadeh. (2023) Effects of myo-inositol plus folic acid on ovarian morphology and oocyte quality in PCOS mouse model. Zygote, pages 1-12.
Crossref
Crossref
Neda Smiljan Severinski, Ulla Marton & Anđelka Radojčić Badovinac. 2023. Polycystic Ovary Syndrome - Symptoms, Causes and Treatment [Working Title]. Polycystic Ovary Syndrome - Symptoms, Causes and Treatment [Working Title].
Giselle Adriana Abruzzese, Mariela Edith Velazquez, Gloria Edith Cerrone & Alicia Beatriz Motta. (2023) Polycystic ovary syndrome in Latin American populations: What is known and what remains unresolved. The Journal of Steroid Biochemistry and Molecular Biology 225, pages 106195.
Crossref
Crossref
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Arturo Bevilacqua, Simona Dinicola & Mariano Bizzarri. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
53
64
.
Lali Pkhaladze, Vittorio Unfer & Didier Dewailly. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
151
165
.
Oliver C. Watkins, Preben Selvam, Reshma Appukuttan Pillai, Victoria K. B. Cracknell-Hazra, Hannah E. J. Yong, Neha Sharma, Amaury Cazenave-Gassiot, Anne K. Bendt, Keith M. Godfrey, Rohan M. Lewis, Markus R. Wenk & Shiao-Yng Chan. (2022) Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental 13C-DHA-metabolism, altering their relationships with birthweight. Scientific Reports 12:1.
Crossref
Crossref
Pablo Lazcano, Michael W. Schmidtke, Chisom J. Onu & Miriam L. Greenberg. (2022) Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase. Journal of Biological Chemistry 298:9, pages 102363.
Crossref
Crossref
Tabatha Petrillo, Elisa Semprini, Veronica Tomatis, Melania Arnesano, Fedora Ambrosetti, Christian Battipaglia, Alessandra Sponzilli, Francesco Ricciardiello, Andrea R. Genazzani & Alessandro D. Genazzani. (2022) Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients. Biomedicines 10:8, pages 1924.
Crossref
Crossref
Hardik Jethaliya, Nirva Gajjar, Vrushank Patel, Shrikalp Deshpande & Roshni Patel. (2022) Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. Reproductive Sciences 29:8, pages 2282-2298.
Crossref
Crossref
Dusan Simic, Tamara Nikolic Turnic, Aleksandra Dimitrijevic, Aleksandar Zivadinovic, Jelena Milosevic-Stevanovic, Dusan Djuric, Vladimir Zivkovic & Vladimir Jakovljevic. (2022)
Potential role of
d
-
chiro
-inositol in reducing oxidative stress in the blood of nonobese women with polycystic ovary syndrome
. Canadian Journal of Physiology and Pharmacology 100:7, pages 629-636.
Crossref
Crossref
Meysam Zarezadeh, Azadeh Dehghani, Amir Hossein Faghfouri, Nima Radkhah, Mohammad Naemi Kermanshahi, Fatemeh Hamedi Kalajahi, Niyaz Mohammadzadeh Honarvar, Zohreh Ghoreishi, Alireza Ostadrahimi & Mehrangiz Ebrahimi Mamaghani. (2021) Inositol supplementation and body mass index: A systematic review and meta‐analysis of randomized clinical trials. Obesity Science & Practice 8:3, pages 387-397.
Crossref
Crossref
L.E. Tumanova & O.V. Kolomiets. (2022) Therapeutic options for pre-gravidary training in women with a history of combined infertility. Reproductive health of woman:2, pages 53-58.
Crossref
Crossref
Reem Magzoub, Elrasheid A.H. Kheirelseid, Claire Perks & Sarah Lewis. (2022) Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 271, pages 38-62.
Crossref
Crossref
James J DiNicolantonio & James H O'Keefe. (2022) Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart 9:1, pages e001989.
Crossref
Crossref
V. Soldat-Stanković, S. Popović-Pejičić, S. Stanković, A. Prtina, G. Malešević, J. Bjekić-Macut, S. Livadas, S. Ognjanović, G. Mastorakos, D. Micić & D. Macut. (2021) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. Journal of Endocrinological Investigation 45:3, pages 583-595.
Crossref
Crossref
K.V. Krasnopolskaya, A.O. Garina, F.F. Burumkulova, K.M. Isakova & K.Sh. Kalseidova. (2022) The role of myo-inositol and calcium L-methylfolate in complex therapy of polycystic ovary syndrome. Problemy reproduktsii 28:6, pages 147.
Crossref
Crossref
Vittorio Unfer, Giovanni Monastra, Marco Tilotta, Gianpiero Forte & Simona Dinicola. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
167
186
.
O.A. Nochvinа & E.V. Slyvka. (2021) Role of inositol and its isomers in glucose metabolism. REPRODUCTIVE ENDOCRINOLOGY:62, pages 104-109.
Crossref
Crossref
Paolo Giovanni Artini, Elisa Malacarne & Vito Cela. (2021) PCOS and Assisted Reproduction Technique: Role and Relevance of Inositols. Endocrines 2:4, pages 515-522.
Crossref
Crossref
Philippe Merviel, Pandora James, Sarah Bouée, Mathilde Le Guillou, Camille Rince, Charlotte Nachtergaele & Véronique Kerlan. (2021) Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive Health 18:1.
Crossref
Crossref
Shakirah Razali, Al’aina Yuhainis Firus Khan, Alfi Khatib, Qamar Uddin Ahmed, Ridhwan Abdul Wahab & Zainul Amiruddin Zakaria. (2021) An In Vitro Anticancer Activity Evaluation of Neolamarckia cadamba (Roxb.) Bosser Leaves’ Extract and its Metabolite Profile. Frontiers in Pharmacology 12.
Crossref
Crossref
Mahmoud Suliman, Michael W. Schmidtke & Miriam L. Greenberg. (2021) A myo-inositol bioassay utilizing an auxotrophic strain of S. cerevisiae. Journal of Microbiological Methods 189, pages 106300.
Crossref
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Crossref
Anupama Bahadur, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani & Rajlaxmi Mundhra. (2021) Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Cureus.
Crossref
Crossref
Ol'ga S. Alyautdina, Viktoriya Y. Prilutskaya & Ekaterina I. Krylova. (2021) The use of inositol stereoisomers for the treatment of patients with clinical and biochemical signs of hyperandrogenism. V.F.Snegirev Archives of Obstetrics and Gynecology 8:2.
Crossref
Crossref
Giovanni Monastra, Ivana Vucenik, Abdel Halim Harrath, Saleh H. Alwasel, Zdravko A. Kamenov, Antonio Simone Laganà, Noemi Monti, Valeria Fedeli & Mariano Bizzarri. (2021) PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol. Frontiers in Endocrinology 12.
Crossref
Crossref
Alessandro D. Genazzani, Ambrosetti Fedora, Despini Giulia, Manzo Alba, Caroli Martina, Arnesano Melania, Petrillo Tabatha, Tomatis Veronica & Andrea R. Genazzani. 2021. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health
67
74
.
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Crossref
Vittorio Unfer, Simona Dinicola, Antonio Simone Laganà & Mariano Bizzarri. (2020) Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. International Journal of Molecular Sciences 21:19, pages 7157.
Crossref
Crossref
Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A. Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E. Nestler & Christophe O. Soulage. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 31:6, pages 435-447.
Crossref
Crossref
M. Caputo, E. Bona, I. Leone, M.T. Samà, A. Nuzzo, A. Ferrero, G. Aimaretti, P. Marzullo & F. Prodam. (2020) Inositols and metabolic disorders: From farm to bedside. Journal of Traditional and Complementary Medicine 10:3, pages 252-259.
Crossref
Crossref
Scott Roseff & Marta Montenegro. (2020) Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary. International Journal of Endocrinology 2020, pages 1-8.
Crossref
Crossref
Kay Neumann & Georg Griesinger. 2020. Reproduktionsmedizin. Reproduktionsmedizin
59
69
.
І. А. Жабченко & О. Р. Сюдмак. (2019) Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods. Reproductive Endocrinology 0:49, pages 43-49.
Crossref
Crossref
Anna Wojciechowska, Adam Osowski, Marcin Jóźwik, Ryszard Górecki, Andrzej Rynkiewicz & Joanna Wojtkiewicz. (2019) Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS. International Journal of Molecular Sciences 20:22, pages 5787.
Crossref
Crossref
Priya Bhide, Jyotsna Pundir, Anil Gudi, Amit Shah, Roy Homburg & Ganesh Acharya. (2019)
The effect of myo‐inositol/di‐chiro‐inositol on markers of ovarian reserve in women with
PCOS
undergoing
IVF
/
ICSI
: A systematic review and meta‐analysis
. Acta Obstetricia et Gynecologica Scandinavica 98:10, pages 1235-1244.
Crossref
Crossref
Inka Miñambres, Gemma Cuixart, Anna Gonçalves & Rosa Corcoy. (2019) Effects of inositol on glucose homeostasis: Systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition 38:3, pages 1146-1152.
Crossref
Crossref
Christian Egarter. (2018) Myo-InositolMyo-inositol. Gynäkologische Endokrinologie 17:1, pages 11-15.
Crossref
Crossref
V.X. Farias, P.N. Uchoa, C.P. Aquino, L.R.G. Britto, M.C. Fonteles, J.H. Leal-Cardoso, K.S. Silva-Alves, A. Havt, M.M.G. Prata, D.B. Heimark, N.R.F. Nascimento & C.F. Santos. (2019) Expression of myo-inositol cotransporters in the sciatic nerve and dorsal root ganglia in experimental diabetes. Brazilian Journal of Medical and Biological Research 52:6.
Crossref
Crossref
Kay Neumann & Georg Griesinger. 2018. Pädiatrische Endokrinologie und Diabetologie. Pädiatrische Endokrinologie und Diabetologie
1
12
.
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson & Cindy Farquhar. (2018) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Antonio Simone Laganà, Amerigo Vitagliano, Marco Noventa, Guido Ambrosini & Rosario D’Anna. (2018) Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics 298:4, pages 675-684.
Crossref
Crossref
A. D. Genazzani, K. Shefer, D. Della Casa, A. Prati, A. Napolitano, A. Manzo, G. Despini & T. Simoncini. (2017) Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. Journal of Endocrinological Investigation 41:5, pages 583-590.
Crossref
Crossref
J Pundir, D Psaroudakis, P Savnur, P Bhide, L Sabatini, H Teede, A Coomarasamy & S Thangaratinam. (2018) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology 125:3, pages 299-308.
Crossref
Crossref
Liuting Zeng & Kailin Yang. (2017) Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 59:1, pages 30-38.
Crossref
Crossref
Kendall C. Case, Michael Salsaa, Wenxi Yu & Miriam L. Greenberg. 2020. Lipid Signaling in Human Diseases. Lipid Signaling in Human Diseases
221
260
.
Susan Arentz, Caroline A. Smith, Jason Abbott & Alan Bensoussan. (2017) Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis. BMC Complementary and Alternative Medicine 17:1.
Crossref
Crossref
Nicolás Mendoza, Laura Pérez, Tommaso Simoncini & Alessandro Genazzani. (2017) Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Reproductive BioMedicine Online 35:5, pages 529-535.
Crossref
Crossref
Mehri Jamilian, Pegah Farhat, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Esmat Aghadavod, Fereshteh Bahmani, Bita Badehnoosh, Hamidreza Jamilian & Zatollah Asemi. (2017)
Expression of Concern
: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial
. Clinical Endocrinology 87:2, pages 194-200.
Crossref
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Crossref
Valeria Tagliaferri, Daniela Romualdi, Valentina Immediata, Simona De Cicco, Christian Di Florio, Antonio Lanzone & Maurizio Guido. (2017)
Metformin
vs
myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study
. Clinical Endocrinology 86:5, pages 725-730.
Crossref
Crossref
Jasmine Plows, Florence Budin, Rebecka Andersson, Valerie Mills, Katherine Mace, Sandra Davidge, Mark Vickers, Philip Baker, Irma Silva-Zolezzi & Joanna Stanley. (2017) The Effects of Myo-Inositol and B and D Vitamin Supplementation in the db/+ Mouse Model of Gestational Diabetes Mellitus. Nutrients 9:2, pages 141.
Crossref
Crossref
G. Simi, A. R. Genazzani, M. E. R. Obino, F. Papini, S. Pinelli, V. Cela & P. G. Artini. (2017) Inositol and In Vitro Fertilization with Embryo Transfer. International Journal of Endocrinology 2017, pages 1-5.
Crossref
Crossref
Alessandro D. Genazzani. (2016) Inositol as putative integrative treatment for PCOS. Reproductive BioMedicine Online 33:6, pages 770-780.
Crossref
Crossref
Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti & Marialuisa Appetecchia. (2016) Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. International Journal of Endocrinology 2016, pages 1-17.
Crossref
Crossref
Saghar Salehpour, Leila Nazari, Sedighe Hoseini, Nasrin Saharkhiz, Fatemeh Ghazi & Mohammad Reza Sohrabi. (2016) A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà & Francesco Orio. (2016) Inositols in the Treatment of Insulin-Mediated Diseases. International Journal of Endocrinology 2016, pages 1-6.
Crossref
Crossref
Deepika Garg & Reshef Tal. (2016) Inositol Treatment and ART Outcomes in Women with PCOS. International Journal of Endocrinology 2016, pages 1-9.
Crossref
Crossref
Guluzar Arzu Turan, Fatma Eskicioglu, Oya Nermin Sivrikoz, Hakan Cengiz, Saban Adakan, Esra Bahar Gur, Sumeyra Tatar, Nur Sahin & Osman Yilmaz. (2015) Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study. Archives of Gynecology and Obstetrics 292:5, pages 1163-1171.
Crossref
Crossref
Marine L. Croze, Alain Géloën & Christophe O. Soulage. (2015)
Abnormalities in
myo
-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary
myo
-inositol supplementation
. British Journal of Nutrition 113:12, pages 1862-1875.
Crossref
Crossref
Antonio Simone Laganà, Luisa Barbaro & Alfonsa Pizzo. (2014) Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol. Archives of Gynecology and Obstetrics 291:5, pages 1181-1186.
Crossref
Crossref
Mariagrazia Stracquadanio & Lilliana CiottaMariagrazia Stracquadanio & Lilliana Ciotta. 2015. Metabolic Aspects of PCOS. Metabolic Aspects of PCOS
89
137
.